Serge Saxonov 10x Genomics, Inc. (TXG) insider trading activity

Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 884,574 shares of TXG, which is worth approximately $13.8 Million. The most recent transaction as insider was on Nov 22, 2021, when has been sold 772 shares (Class A Common Stock) at a price of $148.38 per share, resulting in proceeds of $114,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 885K

0.24% 3M change

2.81% 12M change

Total Value Held $13.8 Million

Serge Saxonov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 22 2021	SELL Open market or private sale	$114,549 $148.38 p/Share	772 Reduced 0.09%	884,609 Class A Common Stock
Nov 02 2021	SELL Open market or private sale	$2,424,000 $161.6 p/Share	15,000 Reduced 1.67%	885,381 Class A Common Stock
Nov 02 2021	BUY Exercise of conversion of derivative security	$68,104 $8.26 p/Share	8,245 Added 0.91%	900,381 Class A Common Stock
Oct 05 2021	SELL Open market or private sale	$2,165,400 $144.36 p/Share	15,000 Reduced 1.65%	892,136 Class A Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$71,598 $8.26 p/Share	8,668 Added 0.95%	907,136 Class A Common Stock
Sep 07 2021	SELL Open market or private sale	$2,820,150 $188.01 p/Share	15,000 Reduced 1.64%	898,468 Class A Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.62%	913,468 Class A Common Stock
Aug 23 2021	SELL Open market or private sale	$120,093 $161.85 p/Share	742 Reduced 0.08%	903,326 Class A Common Stock
Aug 03 2021	SELL Open market or private sale	$2,669,700 $177.98 p/Share	15,000 Reduced 1.63%	904,068 Class A Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.61%	919,068 Class A Common Stock
Jul 06 2021	SELL Open market or private sale	$2,904,750 $193.65 p/Share	15,000 Reduced 1.63%	904,068 Class A Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.61%	919,068 Class A Common Stock
Jun 08 2021	SELL Open market or private sale	$2,789,850 $185.99 p/Share	15,000 Reduced 1.63%	904,068 Class A Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.61%	919,068 Class A Common Stock
Jun 04 2021	SELL Bona fide gift	-	200 Reduced 0.02%	904,068 Class A Common Stock
May 24 2021	SELL Open market or private sale	$125,411 $162.66 p/Share	771 Reduced 0.09%	904,268 Class A Common Stock
May 04 2021	SELL Open market or private sale	$2,760,900 $184.06 p/Share	15,000 Reduced 1.68%	880,468 Class A Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.65%	895,468 Class A Common Stock
Apr 06 2021	SELL Open market or private sale	$2,931,600 $195.44 p/Share	15,000 Reduced 1.68%	880,468 Class A Common Stock
Apr 06 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.65%	895,468 Class A Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	24,571 Added 2.64%	905,039 Class A Common Stock
Mar 12 2021	SELL Open market or private sale	$2,353,350 $156.89 p/Share	15,000 Reduced 1.68%	880,468 Class A Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.65%	895,468 Class A Common Stock
Feb 01 2021	SELL Open market or private sale	$1,765,400 $176.54 p/Share	10,000 Reduced 1.12%	880,468 Class A Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$82,600 $8.26 p/Share	10,000 Added 1.11%	890,468 Class A Common Stock

Serge Saxonov

Chief Executive Officer

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account